Novaestiq
Drew Fine is an accomplished executive with extensive experience in the aesthetics industry, currently serving as Chief Commercial Officer at Novaestiq and CEO/Founder of Dfine Group LLC, providing consulting and fractional leadership. Notable past roles include Fractional Chief Marketing Officer at Rion Aesthetics and Chief Commercial Officer at Advanced MedAesthetic Partners, where significant marketing organizations were established. Previous positions include Vice President Aesthetics at Allergan, where a $2.5 billion portfolio was led, and Vice President Aesthetics Marketing at Galderma, achieving substantial revenue growth and multiple FDA approvals. Drew Fine's background also includes various marketing leadership roles at Eli Lilly and Company and Merck & Company, complemented by an MBA from the University of Michigan and a BA from Duke University.
This person is not in any teams
This person is not in any offices
Novaestiq
Novaestiq is a private venture-backed, growth-phase oriented company that boasts a broad range of aesthetic products that are both practice and patient/consumer focused. With a strong focus on product and service innovation, customer collaboration, and service excellence, Novaestiq is set to redefine industry standards.